OSAKA METROPOLITAN UNIVERSITY
Clinical Trials
31
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (25 trials with phase data)• Click on a phase to view related trials
Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)
- Conditions
- Monkeypox (Mpox)
- First Posted Date
- 2025-07-16
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Osaka Metropolitan University
- Target Recruit Count
- 122
- Registration Number
- NCT07067723
- Locations
- 🇨🇩
Equateur Provincial Public Health Laboratory, Mbandaka, Equateur, Congo, The Democratic Republic of the
Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)
- Conditions
- Mpox (Monkeypox)
- First Posted Date
- 2025-07-09
- Last Posted Date
- 2025-07-09
- Lead Sponsor
- Osaka Metropolitan University
- Target Recruit Count
- 122
- Registration Number
- NCT07055867
- Locations
- 🇨🇩
Equateur Provincial Public Health Laboratory, Mbandaka, Equateur, Congo, The Democratic Republic of the
Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)
- Conditions
- Mpox (Monkeypox)
- First Posted Date
- 2025-05-22
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Osaka Metropolitan University
- Target Recruit Count
- 144
- Registration Number
- NCT06984705
- Locations
- 🇨🇩
Equateur Provincial Public Health Laboratory, Mbandaka, Equateur, Congo, The Democratic Republic of the
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
- Conditions
- Type 2 Diabetes Mellitus (T2DM)Type 2 DiabetesDiabetes MellitusHypertensionHyperglycemiaHyperlipidemiaDyslipidemiaHyperuricemia or GoutHyperuricemia, GoutObesity
- First Posted Date
- 2024-11-19
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Osaka Metropolitan University
- Target Recruit Count
- 2000
- Registration Number
- NCT06694012
- Locations
- 🇯🇵
The Ohtori Health Promotion Center, Sakai, Osaka, Japan
Polyethylene Wear Particle Analysis of THA
- Conditions
- Hip ArthropathyWear of Articular Bearing Surface of Prosthetic Joint
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Osaka Metropolitan University
- Target Recruit Count
- 90
- Registration Number
- NCT06432543
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇯🇵Osaka Metropolitan University, Osaka, Japan
- Prev
- 1
- 2
- Next
News
Japanese Researchers Develop GAI-17, Novel Stroke Drug with Six-Hour Treatment Window
Researchers at Osaka Metropolitan University developed GAI-17, a novel stroke treatment that significantly reduces brain cell death and paralysis in animal models by inhibiting GAPDH protein aggregation.
Shionogi and Osaka Metropolitan University Form Strategic Alliance to Combat Infectious Diseases
Shionogi and Osaka Metropolitan University have established a comprehensive collaboration agreement focused on infectious disease research, diagnostics development, and public health system strengthening.
Canagliflozin Shows Promise in Protecting Kidney Health in Type 2 Diabetes Patients
A Japanese study explored the potential of SGLT2 inhibitors, particularly canagliflozin, in protecting kidney health in patients with type 2 diabetes.
Chinese Herbal Medicine Shows Promise in Restoring Cognitive Function in Dementia Models
Researchers found that Ziziphus jujuba Miller var. spinosa, a traditional Chinese medicine, restored cognitive and motor functions in dementia model mice.
BMI Thresholds Impact Mortality Risk in NSCLC Immunotherapy vs. Chemotherapy
A study of over 500,000 lung cancer patients reveals that BMI affects mortality risk differently in immunotherapy versus chemotherapy.